Medical Disposables & Supplies Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Kurt Boothe

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	4yrs
Proprietà del CEO	19.4%
Durata media del management	4.1yrs
Durata media del Consiglio di amministrazione	10.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Kurt Boothe

4yrs

Mandato

Mr. Kurt Boothe was a Company Secretary and General Manager of Medical Disposables & Supplies Limited until November 01, 2020 and serves as Executive Director. He serves as Chief Executive Officer of Medic...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Kurt Boothe	CEO & Executive Director	4yrs	Nessun dato	19.44% JMD 107.4m
Myrtis Boothe	Founder & Executive Director	no data	Nessun dato	19% JMD 105.0m
Raymond Ernandez	Chief Financial Officer	no data	Nessun dato	Nessun dato
Bertino Gordon	Operations Manager	4.7yrs	Nessun dato	Nessun dato
Nadine Banton	Human Resource & Administrative Manager	4.1yrs	Nessun dato	Nessun dato
Kandise Morgan-Small	Sales & Marketing Manager	no data	Nessun dato	Nessun dato
Nikeisha Hill	Executive Director	no data	Nessun dato	19% JMD 105.0m

4.1yrs

Durata media

Gestione esperta: Il team dirigenziale di MDS è considerato esperto (durata media dell'incarico 4.1 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Kurt Boothe	CEO & Executive Director	no data	Nessun dato	19.44% JMD 107.4m
Myrtis Boothe	Founder & Executive Director	no data	Nessun dato	19% JMD 105.0m
Nikeisha Hill	Executive Director	no data	Nessun dato	19% JMD 105.0m
Vincent Lawrence	Lead Independent Director	10.9yrs	JA$613.75k	Nessun dato
Sheree Martin	Director	less than a year	Nessun dato	Nessun dato
Winston Boothe	Chairman	no data	JA$713.75k	19% JMD 105.0m
Dahlia McDaniel-Dickson	Independent Non-Executive Director	10.9yrs	JA$643.75k	0.55% JMD 3.1m

10.9yrs

Durata media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di MDS è composto da personale esperto e esperto (durata media dell'incarico 10.9 anni).

Medical Disposables & Supplies Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Medical Disposables & Supplies Limited Announces Board Appointments

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Medical Disposables & Supplies Limited to Report Fiscal Year 2024 Final Results on Nov 29, 2024

Medical Disposables & Supplies Limited Announces Board Appointments

Full year 2024 earnings released: JA$1.11 loss per share (vs JA$0.27 profit in FY 2023)

New minor risk - Share price stability

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023)

New major risk - Share price stability

Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023)

Investor sentiment deteriorates as stock falls 24%

First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: JA$0.27 (vs JA$0.37 in FY 2022)

Investor sentiment improves as stock rises 22%

Third quarter 2023 earnings released: EPS: JA$0.11 (vs JA$0.11 in 3Q 2022)

Investor sentiment improves as stock rises 18%

Investor sentiment improved over the past week

Upcoming dividend of JA$0.09 per share

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: JA$0.37 (vs JA$0.27 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of JA$0.07 per share

First quarter 2022 earnings released: EPS JA$0.10 (vs JA$0.03 loss in 1Q 2021)

Full year 2021 earnings released

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: JA$4.74

Third quarter 2021 earnings released: EPS JA$0.10 (vs JA$0.02 in 3Q 2020)

Second quarter 2021 earnings released: JA$0.02 loss per share

Market pulls back on stock over the past week

New 90-day low: JA$4.30

New 90-day low - JA$4.67

First quarter earnings released

New 90-day low - JA$5.07

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media